OncoTargets and Therapyhttps://www.dovepress.com/feed/journal/23New articles released by Dove Press for OncoTargets and Therapyen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press OncoTargets and TherapyOncoTargets and Therapyhttps://www.dovepress.com/feed/journal/23https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140A Nomogram Integrating HOXA9 Expression and Clinicopathological Factors for Predicting Postoperative Recurrence in Gastric Cancer: A Single-Center Retrospective Studyhttps://www.dovepress.com/a-nomogram-integrating-hoxa9-expression-and-clinicopathological-factor-peer-reviewed-fulltext-article-OTTOncoTargets and TherapySat, 06 Jun 2026 17:00:00 +1200https://doi.org/10.2147/OTT.S596270lncRNA FBXL19-AS1 Regulates Osteosarcoma Cell Proliferation, Migration and Invasion by Sponging miR-346 [Retraction]https://www.dovepress.com/retraction-lncrna-fbxl19-as1-regulates-osteosarcoma-cell-proliferation-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyThu, 04 Jun 2026 18:05:00 +1200https://doi.org/10.2147/OTT.S629832Nodal Regulates Bladder Cancer Cell Migration and Invasion via the ALK/Smad Signaling Pathway [Retraction]https://www.dovepress.com/retraction-nodal-regulates-bladder-cancer-cell-migration-and-invasion--peer-reviewed-fulltext-article-OTTOncoTargets and TherapyThu, 04 Jun 2026 18:00:00 +1200https://doi.org/10.2147/OTT.S629839Acquired BRAF-AGK Fusion Following Osimertinib Plus Savolitinib in EGFR-Mutated MET-Amplified Non-Small-Cell Lung Cancer: Durable Response to Gefitinib and Trametinib in a Case Reporthttps://www.dovepress.com/acquired-braf-agk-fusion-following-osimertinib-plus-savolitinib-in-egf-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyWed, 03 Jun 2026 04:35:00 +1200https://doi.org/10.2147/OTT.S605699Bergamottin Induces DNA Damage and Inhibits Malignant Progression in Melanoma by Modulating miR-145/Cyclin D1 Axis [Retraction]https://www.dovepress.com/retraction-bergamottin-induces-dna-damage-and-inhibits-malignant-progr-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyFri, 22 May 2026 17:30:00 +1200https://doi.org/10.2147/OTT.S625401Elevated Expression of Tiam1 Is Associated with Poor Prognosis and Promotes Tumor Progression in Pancreatic Cancer [Retraction]https://www.dovepress.com/retraction-elevated-expression-of-tiam1-is-associated-with-poor-progno-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyWed, 20 May 2026 19:45:00 +1200https://doi.org/10.2147/OTT.S625411Evodiamine Inactivates NF-κB and Potentiates the Antitumor Effects of Gemcitabine on Tongue Cancer Both in vitro and in vivo [Retraction]https://www.dovepress.com/retraction-evodiamine-inactivates-nf-kappab-and-potentiates-the-antitu-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyWed, 20 May 2026 19:40:00 +1200https://doi.org/10.2147/OTT.S625409Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohortshttps://www.dovepress.com/efficacy-and-safety-of-regorafenib-with-or-without-immune-checkpoint-i-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 19 May 2026 03:10:00 +1200https://doi.org/10.2147/OTT.S606160Tanshinol Inhibits the Growth, Migration and Invasion of Hepatocellular Carcinoma Cells via Regulating the PI3K-AKT Signaling Pathway [Retraction]https://www.dovepress.com/retraction-tanshinol-inhibits-the-growth-migration-and-invasion-of-hep-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyMon, 18 May 2026 16:30:00 +1200https://doi.org/10.2147/OTT.S623062Next-Generation Sequence Detects ARAP3 as a Novel Oncogene in Papillary Thyroid Carcinoma [Retraction]https://www.dovepress.com/retraction-next-generation-sequence-detects-arap3-as-a-novel-oncogene--peer-reviewed-fulltext-article-OTTOncoTargets and TherapySat, 16 May 2026 19:20:00 +1200https://doi.org/10.2147/OTT.S624308miR-495 Inhibits Proliferation, Migration, and Invasion and Induces Apoptosis via Inhibiting PBX3 in Melanoma Cells [Retraction]https://www.dovepress.com/retraction-mir-495-inhibits-proliferation-migration-and-invasion-and-i-peer-reviewed-fulltext-article-OTTOncoTargets and TherapySat, 16 May 2026 19:15:00 +1200https://doi.org/10.2147/OTT.S624309PLK1 Contributes to Autophagy by Regulating MYC Stabilization in Osteosarcoma Cells [Retraction]https://www.dovepress.com/retraction-plk1-contributes-to-autophagy-by-regulating-myc-stabilizati-peer-reviewed-fulltext-article-OTTOncoTargets and TherapySat, 16 May 2026 19:10:00 +1200https://doi.org/10.2147/OTT.S624305The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancerhttps://www.dovepress.com/the-epha3-antibody-enhances-cd47-antibody-mediated-phagocytosis-by-rep-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyFri, 15 May 2026 06:25:00 +1200https://doi.org/10.2147/OTT.S595937Research on Targeted Therapy for Malignant Tumors of the Biliary Tracthttps://www.dovepress.com/research-on-targeted-therapy-for-malignant-tumors-of-the-biliary-tract-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 12 May 2026 01:30:00 +1200https://doi.org/10.2147/OTT.S593457Clinical Application of the Right Liver Hanging Maneuver for Laparoscopic Resection of Segment 6 Hepatocellular Carcinomahttps://www.dovepress.com/clinical-application-of-the-right-liver-hanging-maneuver-for-laparosco-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyMon, 04 May 2026 23:55:00 +1200https://doi.org/10.2147/OTT.S576322MiR-155-5p Accelerates the Metastasis of Cervical Cancer Cell via Targeting TP53INP1 [Retraction]https://www.dovepress.com/retraction-mir-155-5p-accelerates-the-metastasis-of-cervical-cancer-ce-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyMon, 04 May 2026 17:35:00 +1200https://doi.org/10.2147/OTT.S620871miR-214-3p Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Endometrial Cancer Cells by Targeting TWIST1 [Retraction]https://www.dovepress.com/retraction-mir-214-3p-inhibits-epithelial-to-mesenchymal-transition-an-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyMon, 04 May 2026 17:15:00 +1200https://doi.org/10.2147/OTT.S620877Advances in the Treatment of Breast Cancer at Different Stages of Pregnancyhttps://www.dovepress.com/advances-in-the-treatment-of-breast-cancer-at-different-stages-of-preg-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyWed, 29 Apr 2026 23:55:00 +1200https://doi.org/10.2147/OTT.S586690The Role of Genomics in the Development and Treatment of Multiple Myeloma: Understanding the Challenges and Opportunitieshttps://www.dovepress.com/the-role-of-genomics-in-the-development-and-treatment-of-multiple-myel-peer-reviewed-fulltext-article-OTTOncoTargets and TherapySat, 18 Apr 2026 04:45:00 +1200https://doi.org/10.2147/OTT.S595435Assessment of the Correlation Between Hypoalbuminemia and Adverse Effects of Oral Anticancer Medications in Adult Patients with Solid Tumors: A Single-Center Retrospective Cohort Study in Saudi Arabiahttps://www.dovepress.com/assessment-of-the-correlation-between-hypoalbuminemia-and-adverse-effe-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyThu, 16 Apr 2026 04:35:00 +1200https://doi.org/10.2147/OTT.S554707let-7d Suppresses Proliferation and Invasion and Promotes Apoptosis of Meningioma by Targeting AEG-1 [Retraction]https://www.dovepress.com/retraction-let-7d-suppresses-proliferation-and-invasion-and-promotes-a-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyWed, 08 Apr 2026 17:55:00 +1200https://doi.org/10.2147/OTT.S614704Extracellular Vesicles in Pancreatic Cancer Function and Potential Clinical Applicationshttps://www.dovepress.com/extracellular-vesicles-in-pancreatic-cancer-function-and-potential-cli-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyWed, 08 Apr 2026 00:05:00 +1200https://doi.org/10.2147/OTT.S591622Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]https://www.dovepress.com/retraction-doxorubicin-and-edelfosine-combo-loaded-lipidndashpolymer-h-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 07 Apr 2026 21:50:00 +1200https://doi.org/10.2147/OTT.S614697miR-218 Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction]https://www.dovepress.com/retraction-mir-218-overexpression-suppresses-tumorigenesis-of-papillar-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 07 Apr 2026 20:15:00 +1200https://doi.org/10.2147/OTT.S614707Downregulation of Long Noncoding RNA TUG1 Inhibits Proliferation and Induces Apoptosis Through the TUG1/miR-142/ZEB2 Axis in Bladder Cancer Cells [Retraction]https://www.dovepress.com/retraction-downregulation-of-long-noncoding-rna-tug1-inhibits-prolifer-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 07 Apr 2026 20:10:00 +1200https://doi.org/10.2147/OTT.S614701Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: A Single-Center Case Series of Five Patientshttps://www.dovepress.com/diffuse-sclerosing-variant-of-papillary-thyroid-carcinoma-a-single-cen-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 07 Apr 2026 20:05:00 +1200https://doi.org/10.2147/OTT.S595202Identification of an m7G-Related lncRNA Signature for Prognostic Prediction and Immune Landscape Characterization in Early Gastric Cancerhttps://www.dovepress.com/identification-of-an-m7g-related-lncrna-signature-for-prognostic-predi-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 07 Apr 2026 20:00:00 +1200https://doi.org/10.2147/OTT.S582487High-Dose Twice-Daily Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Real-World Retrospective Experience from Two Tertiary Centershttps://www.dovepress.com/high-dose-twice-daily-thoracic-radiotherapy-for-limited-stage-small-ce-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyTue, 31 Mar 2026 17:50:00 +1300https://doi.org/10.2147/OTT.S576505Enhancing Immunotherapy in Diffuse Large B-Cell Lymphoma: The Synergistic Potential of Metabolic Checkpoint Inhibitors and Immunomodulationhttps://www.dovepress.com/enhancing-immunotherapy-in-diffuse-large-b-cell-lymphoma-the-synergist-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyMon, 30 Mar 2026 17:50:00 +1300https://doi.org/10.2147/OTT.S581821A Novel Strategy for Treating Elderly Patients with Advanced Non-Small Cell Lung Cancer: Exploring the Efficacy and Safety of Anlotinib Combined with PD-1/PD-L1 Inhibitorshttps://www.dovepress.com/a-novel-strategy-for-treating-elderly-patients-with-advanced-non-small-peer-reviewed-fulltext-article-OTTOncoTargets and TherapyMon, 30 Mar 2026 16:30:00 +1300https://doi.org/10.2147/OTT.S578933